<?xml version="1.0" encoding="UTF-8"?>
<p>Prevention of viral pneumonia is mainly limited to influenza vaccines since the formalin-inactivated RSV vaccine in the 1960s failed secondary to adverse events (
 <xref rid="R64" ref-type="bibr">64</xref>). However, oral adenovirus vaccination has been used in military populations with 100-fold reduction of respiratory illnesses (
 <xref rid="R65" ref-type="bibr">65</xref>, 
 <xref rid="R66" ref-type="bibr">66</xref>). Production of this vaccine was stopped in 1999 but was reintroduced in 2011, leading to a dramatic and sustained decrease of acute respiratory distress outbreaks among U.S. Army trainees (
 <xref rid="R67" ref-type="bibr">67</xref>, 
 <xref rid="R68" ref-type="bibr">68</xref>).
</p>
